Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Only 1 out of 5...

    Only 1 out of 5 protected due to smoking ban globally: WHO

    Written by Dr. Kamal Kant Kohli Kohli Published On 2019-07-29T09:20:06+05:30  |  Updated On 29 July 2019 9:20 AM IST
    Only 1 out of 5 protected due to smoking ban globally: WHO

    Smoking bans by various countries have yielded favorable results but not to the extent it is desirable and at present only 1 out of 5 persons is protected due to smoking ban, states World Health Organization report.





    Only 1 in 5 people are protected by complete tobacco smoking bans in indoor public spaces and workplaces. 6 in 10 tobacco users want to quit and with proven help, they can more than double their chances of quitting. “Quitting tobacco is one of the best things any person can do for their own health,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. Currently, there are an estimated 1.1 billion smokers, around 80% of whom live in low- and middle-income countries.

    Many governments are making progress in the fight against tobacco, with 5 billion people today living in countries that have introduced smoking bans, graphic warnings on packaging and other effective tobacco control measures - four times more people than a decade ago. But a new World Health Organization report shows many countries are still not adequately implementing policies, including helping people quit tobacco, that can save lives from tobacco.

    The seventh World Health Organization Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.

    These measures, like the “MPOWER” interventions, have been shown to save lives and reduce costs from averted healthcare expenditure. The MPOWER report was launched in 2007 to promote government action on six tobacco control strategies in-line with the WHO FCTC to:

    • Monitor tobacco use and prevention policies.

    • Protect people from tobacco smoke.

    • Offer help to quit tobacco use.

    • Warn people about the dangers of tobacco.

    • Enforce bans on tobacco advertising, promotion and sponsorship.

    • Raise taxes on tobacco.


    Tobacco cessation services must be stepped up

    The focus of the latest report is on the progress countries have made to help tobacco users quit. It is being launched today in Brazil, a country that has become the second, after Turkey, to fully implement all the MPOWER measures at the highest level of achievement.

    Dr Tedros Adhanom Ghebreyesus, World Health Organization Director-General, said governments should implement cessation services as part of efforts to ensure universal health coverage for their citizens.

    “Quitting tobacco is one of the best things any person can do for their own health,” said Dr Tedros. “The MPOWER package gives governments the practical tools to help people kick the habit, adding years to their life and life to their years.”

    Progress is being made, with 2.4 billion people living in countries now providing comprehensive cessation services (2 billion more than in 2007). But only 23 countries are providing cessation services at the best-practice level, making it the most under-implemented MPOWER measure in terms of number of countries offering full coverage.

    Tobacco cessation services include national toll-free quit lines, “mCessation” services to reach larger populations via mobile phones, counselling by primary health care providers and cost-covered nicotine replacement therapy.

    Michael R. Bloomberg, WHO Global Ambassador for Noncommunicable Diseases and Injuries and founder of Bloomberg Philanthropies, said the report shows government-led efforts to help people quit tobacco work when properly implemented.

    “More countries are making tobacco control a priority and saving lives, but there’s still much more work to be done,” said Mr Bloomberg. “The WHO’s new report shines a spotlight on global efforts to help people quit using tobacco and it details some of our most important gains.”

    The report, funded by Bloomberg Philanthropies, showed that while only 23 countries have implemented cessation support policies at the highest level, 116 more provide fully or partially cost-covered services in some or most health facilities, and another 32 offer services but do not cost-cover them, demonstrating a high level of public demand for support to quit.

    Tobacco use has also declined proportionately in most countries, but population growth means the total number of people using tobacco has remained stubbornly high. Currently, there are an estimated 1.1 billion smokers, around 80% of whom live in low- and middle-income countries (LMICs).

    Since the last report, issued in 2017, the WHO report on the global tobacco epidemic, 2019, also finds that:

    • 36 countries have introduced one or more MPOWER measures at the highest level of achievement.

    • Over half of the world’s population – 3.9 billion people living in 91 countries – benefit from large graphic pack warnings featuring all recommended characteristics, making it the MPOWER measure with both the highest population coverage and the most countries covered.

    • 14 countries have implemented large graphic warning laws at best practice level, making it the MPOWER policy with the greatest growth in terms of country uptake during the last two years.

    • The greatest growth in population coverage was seen in tobacco taxation. The population coverage from this MPOWER policy has almost doubled from 8% in 2016 to 14% in 2018. But while being the most effective way to reduce tobacco use, taxation is still the MPOWER policy with the lowest population coverage.

    • Of the 5 billion people protected by at least one MPOWER policy, 3.9 billion live in LMICs (or 61% of all people in LMICs).

    • 59 countries have yet to adopt a single MPOWER measure at the highest level of achievement – 49 are LMICs.

    • In the world’s 34 low-income countries, 17 today have at least one MPOWER policy in place at best-practice level compared to three in 2007, showing that income level is not a barrier to best-practice tobacco control


    For each MPOWER measure, there have been new countries that have implemented some of the measures at the best practice level since the last report:

    • 7 (Antigua and Barbuda, Benin, Burundi, Gambia, Guyana, Niue and Tajikistan) have adopted complete smoke-free laws covering all indoor public places and workplaces.

    • 4 (Czechia, Saudi Arabia, Slovakia and Sweden) advanced to best-practice level with cessation services. But during the same period, six other countries dropped from the highest group, resulting in a net loss of two countries.

    • 14 (Barbados, Cameroon, Croatia, Cyprus, Georgia, Guyana, Honduras, Luxembourg, Pakistan, Saint Lucia, Saudi Arabia, Slovenia, Spain and Timor-Leste) adopted large graphic pack warnings.

    • 10 (Antigua and Barbuda, Azerbaijan, Benin, Congo, Democratic Republic of the Congo, Gambia, Guyana, Niue, Saudi Arabia and Slovenia) introduced.

    • 10 (Andorra, Australia, Brazil, Colombia, Egypt, Mauritius, Montenegro, New Zealand, North Macedonia and Thailand) raised taxes to comprise at least 75% of retail prices.







    globallyonlyprotectedsmokingWHO

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok